- Home
- VTYX vs LODE Comparison
VTYX vs LODE Comparison
Compare VTYX & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- LODE
- Stock Information
- Founded
- VTYX 2018
- LODE 2008
- Country
- VTYX United States
- LODE United States
- Employees
- VTYX N/A
- LODE N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- LODE Major Chemicals
- Sector
- VTYX Health Care
- LODE Industrials
- Exchange
- VTYX Nasdaq
- LODE Nasdaq
- Market Cap
- VTYX 154.9M
- LODE 168.0M
- IPO Year
- VTYX 2021
- LODE N/A
- Fundamental
- Price
- VTYX $8.09
- LODE $2.77
- Analyst Decision
- VTYX Buy
- LODE Hold
- Analyst Count
- VTYX 3
- LODE 1
- Target Price
- VTYX $12.50
- LODE $4.00
- AVG Volume (30 Days)
- VTYX 9.8M
- LODE 1.5M
- Earning Date
- VTYX 11-06-2025
- LODE 10-30-2025
- Dividend Yield
- VTYX N/A
- LODE N/A
- EPS Growth
- VTYX N/A
- LODE N/A
- EPS
- VTYX N/A
- LODE N/A
- Revenue
- VTYX N/A
- LODE $2,778,445.00
- Revenue This Year
- VTYX N/A
- LODE $7.65
- Revenue Next Year
- VTYX N/A
- LODE $1,093.72
- P/E Ratio
- VTYX N/A
- LODE N/A
- Revenue Growth
- VTYX N/A
- LODE 48.99
- 52 Week Low
- VTYX $0.78
- LODE $1.67
- 52 Week High
- VTYX $9.50
- LODE $10.10
- Technical
- Relative Strength Index (RSI)
- VTYX 76.14
- LODE 38.51
- Support Level
- VTYX $5.75
- LODE $2.96
- Resistance Level
- VTYX $9.50
- LODE $3.48
- Average True Range (ATR)
- VTYX 0.78
- LODE 0.29
- MACD
- VTYX 0.33
- LODE -0.08
- Stochastic Oscillator
- VTYX 76.85
- LODE 3.75
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.